Drug Approval | July 26, 2024
Sun Pharmaceutical receives USFDA approval for oral JAK inhibitor ‘Leqselvi’
Leqselvi delivered statistically significant efficacy across two Phase 3 clinical trials
Leqselvi delivered statistically significant efficacy across two Phase 3 clinical trials
There is an urgent need for more therapeutic treatment options for patients with painful osteoarthritis
Global Initiative on Digital Health (GIDH) was launched by the WHO and the Government of India during the G20 Health Working Group meeting in Gandhinagar last year
Signs MoU with the Govt. of Gujarat at Vibrant Gujarat Summit
Lays Foundation Stone of 6 new facilities at AIIMS Bhopal and inaugurates a slew of facilities in Madhya Pradesh
Atlas Life Sciences (India) has successfully commenced the commercial production of API - Intermediate at its new plant at Chhatral,
The divestment is a part of Fortis' ongoing portfolio rationalization strategy
ASMD is highly variable and the age of onset, specific symptoms and severity of the disorder can vary dramatically from one person to another
The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials
WINLEVI works differently from any other topical acne treatment
Subscribe To Our Newsletter & Stay Updated
